CAD 0.07
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 542.27 Thousand CAD | 99.62% |
2022 | -3.01 Million CAD | 39.89% |
2021 | -5 Million CAD | 14.69% |
2020 | -5.87 Million CAD | 23.4% |
2019 | -7.66 Million CAD | -248.98% |
2018 | -2.19 Million CAD | -26436.21% |
2017 | 8340.00 CAD | 163.89% |
2016 | -13.05 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q3 | -303.31 Thousand CAD | 70.04% |
2024 Q2 | -1.01 Million CAD | -784.83% |
2024 Q1 | 147.83 Thousand CAD | 208.62% |
2023 Q2 | -17.5 Thousand CAD | 96.72% |
2023 Q1 | -533.47 Thousand CAD | 39.65% |
2023 FY | -11.43 Thousand CAD | 99.62% |
2023 Q4 | 47.9 Thousand CAD | -88.79% |
2023 Q3 | 427.27 Thousand CAD | 2541.4% |
2022 Q4 | -884.03 Thousand CAD | 9.82% |
2022 Q3 | -980.33 Thousand CAD | -100.73% |
2022 Q2 | -488.37 Thousand CAD | 25.8% |
2022 Q1 | -658.17 Thousand CAD | 62.37% |
2022 FY | -3.01 Million CAD | 39.89% |
2021 FY | -5 Million CAD | 14.69% |
2021 Q2 | -1.05 Million CAD | -16.17% |
2021 Q3 | -911.62 Thousand CAD | 13.28% |
2021 Q4 | -1.74 Million CAD | -91.88% |
2021 Q1 | -904.84 Thousand CAD | 54.63% |
2020 Q4 | -1.99 Million CAD | -84.23% |
2020 Q1 | -1.67 Million CAD | 25.74% |
2020 Q2 | -1.45 Million CAD | 13.25% |
2020 FY | -5.87 Million CAD | 23.4% |
2020 Q3 | -1.08 Million CAD | 25.51% |
2019 Q3 | -1.53 Million CAD | 50.75% |
2019 FY | -7.66 Million CAD | -248.98% |
2019 Q4 | -2.25 Million CAD | -46.75% |
2019 Q2 | -3.12 Million CAD | -5978.85% |
2019 Q1 | -51.34 Thousand CAD | -28.83% |
2018 Q1 | -21.02 Thousand CAD | 52.0% |
2018 Q2 | 53.53 Thousand CAD | 354.65% |
2018 FY | -2.19 Million CAD | -26436.21% |
2018 Q3 | -18.99 Thousand CAD | -135.48% |
2018 Q4 | -39.85 Thousand CAD | -109.81% |
2017 FY | 8340.00 CAD | 163.89% |
2017 Q3 | -22.8 Thousand CAD | 0.0% |
2017 Q4 | -43.8 Thousand CAD | -92.08% |
2016 FY | -13.05 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Aion Therapeutic Inc. | -1.19 Million CAD | 145.533% |
Ayurcann Holdings Corp. | -3.25 Million CAD | 116.681% |
Blueberries Medical Corp. | -1.22 Million CAD | 144.21% |
The BC Bud Corporation | -1.22 Million CAD | 144.322% |
BioNxt Solutions Inc. | -6.36 Million CAD | 108.516% |
CordovaCann Corp. | -2.51 Million CAD | 121.582% |
Christina Lake Cannabis Corp. | -880.54 Thousand CAD | 161.583% |
Captor Capital Corp. | 655.2 Thousand CAD | 17.237% |
City View Green Holdings Inc. | -996.45 Thousand CAD | 154.42% |
1CM Inc. | 300.79 Thousand CAD | -80.281% |
Global Hemp Group Inc. | -551.7 Thousand CAD | 198.289% |
Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 113.979% |
IM Cannabis Corp. | -12.17 Million CAD | 104.454% |
Lobe Sciences Ltd. | -3.35 Million CAD | 116.142% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | 238.258% |
Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 117.02% |
Ovation Science Inc. | -764 Thousand CAD | 170.977% |
Pharmadrug Inc. | -1.33 Million CAD | 140.619% |
Captiva Verde Wellness Corp. | -1.14 Million CAD | 147.485% |
RAMM Pharma Corp. | -7.08 Million CAD | 107.653% |
RIV Capital Inc. | 1.78 Million CAD | 69.539% |
Revive Therapeutics Ltd. | -3.28 Million CAD | 116.502% |
Red White & Bloom Brands Inc. | -8.76 Million CAD | 106.184% |
SLANG Worldwide Inc. | -5.98 Million CAD | 109.058% |
1933 Industries Inc. | -9.34 Million CAD | 105.8% |
Red Light Holland Corp. | -6.44 Million CAD | 108.412% |
Top Strike Resources Corp. | -784.8 Thousand CAD | 169.096% |
Xebra Brands Ltd. | -1.55 Million CAD | 134.883% |
Adastra Holdings Ltd. | -1.79 Million CAD | 130.231% |